Results 271 to 280 of about 482,975 (382)

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali   +4 more
wiley   +1 more source

Correction: Anticoagulant therapy and altered tissue factor expression protect against experimental placental and cerebral malaria. [PDF]

open access: yesPLoS Pathog
Andrew AK   +7 more
europepmc   +1 more source

Update of the guidelines for lupus anticoagulant detection

open access: yesJournal of Thrombosis and Haemostasis, 2009
V. Pengo   +6 more
semanticscholar   +1 more source

Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan’s National Claims Database

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Disproportionality analyses suggested a cardiovascular risk signal for romosozumab, while statistically significant associations were not found in the real‐world database studies. Therefore, a larger comparative study was necessary to examine this signal.
Hotaka Maruyama   +5 more
wiley   +1 more source

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

open access: yesEuropean Heart Journal, 2016
H. Diener   +15 more
semanticscholar   +1 more source

Metformin in the Horse: Pharmacokinetics and Detection Times Using Monte Carlo Simulations

open access: yesDrug Testing and Analysis, EarlyView.
In recent years, the detection of metformin in blood and urine samples collected from racehorses has raised concern among regulators. This study describes blood and urine concentrations and the pharmacokinetics of metformin following IV and oral administration to horses. Data presented here can be used to establish screening limits and withdrawal times
Megan E. Jacobs   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy